Active Biotech AB (OSTO:ACTI) OCF Yield %: -21.13 (As of Jun. 24, 2026)


OSTO:ACTI Active Biotech AB OSTO:ACTI
28 GF Score
Price kr5.75
! 1 Warning Sign
View Full Analysis

What is Active Biotech AB OCF Yield %?

Active Biotech AB OSTO:ACTI +2.31% 28 OCF Yield % is -21.13 as of Jun. 24, 2026. GuruFocus rates OSTO:ACTI with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Active Biotech AB ranks worse than 68.41% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Active Biotech AB's Trailing 12-Month Cash Flow from Operations is kr-31.30 Mil, and Market Cap is kr151.57 Mil. Therefore, Active Biotech AB's OCF Yield % for today is -21.13%.

The historical rank and industry rank for Active Biotech AB's OCF Yield % or its related term are showing as below:

OSTO:ACTI' s OCF Yield % Range Over the Past 10 Years
Min: -129.17   Med: -13.78   Max: -4.13
Current: -21.13


During the past 13 years, the highest OCF Yield % of Active Biotech AB was -4.13%. The lowest was -129.17%. And the median was -13.78%.

OSTO:ACTI's OCF Yield % is ranked worse than
68.41% of 1418 companies
in the Biotechnology industry
Industry Median: -8.55 vs OSTO:ACTI: -21.13

Active Biotech AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Active Biotech AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Active Biotech AB OCF Yield % Related Terms


Active Biotech AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Active Biotech AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Active Biotech AB OCF Yield % Chart

Active Biotech AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.75 -21.53 -27.70 -34.86 -26.72

Active Biotech AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.06 -15.31 -14.47 -23.75 -22.11

OSTO:ACTI vs VRTX, REGN, ALNY: OCF Yield % Comparison

For the Biotechnology subindustry, Active Biotech AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's OCF Yield % falls into.


OSTO:ACTI
28GF Score
Active Biotech AB OSTO:ACTI
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Active Biotech AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Active Biotech AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-32.399 / 121.2606
=-26.72%

Active Biotech AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-8 * 4 / 144.72189
=-22.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -21.13 mean?
Active Biotech AB (OSTO:ACTI) has a OCF Yield % of -21.13 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Active Biotech AB and its competitors. According to the industry distribution chart, Active Biotech AB ranks #970 out of 1418 companies in the Biotechnology industry, placing it in the top 68.4%.
Is Active Biotech AB's OCF Yield % too high?
Active Biotech AB's current OCF Yield % is -21.13. Based on the distribution chart, Active Biotech AB ranks #970 out of 1418 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Active Biotech AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Active Biotech AB's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Active Biotech AB ranks #970 out of 1418 companies for OCF Yield %. This places Active Biotech AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Active Biotech AB and its competitors. Active Biotech AB's current OCF Yield % is -21.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Active Biotech AB stock overvalued right now?
Active Biotech AB (OSTO:ACTI) has a current OCF Yield % of -21.13. The current OCF Yield % is -21.13. Active Biotech AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Active Biotech AB (OSTO:ACTI), the current OCF Yield % is -21.13 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Active Biotech AB Business Description

Other Exchanges 0GQU:UKBTP:Germany
Address Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy. Its project portfolio includes both small orally active immunomodulatory molecules and antibody-based immunotherapy. Its pipeline products are: Tasquinimod, Laquinimod, and Naptumomab.
28GF Score

Get the complete analysis for OSTO:ACTI

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr5.75
Price